Navigation Links
New England Journal of Medicine Publishes Results From the Landmark ATHENA Trial with Multaq(R) (dronedarone) in Atrial Fibrillation
Date:2/11/2009

/i>" commented Dr. Stefan H. Hohnloser J.W., Goethe University's Division of Clinical Electrophysiology, Frankfurt, Germany, principal investigator of the ATHENA study.

Reported significant adverse events in the Multaq(R) arm vs. placebo arm included diarrhea (9.7% vs. 6.2%), nausea (5.3% vs. 3.1%), bradycardia (3.5% vs. 1.2%), QT-interval prolongation (1.7% vs. 0.6%); skin disorders (10.3% vs. 7.6%) consisting mainly of rash, and an increase in blood creatinine (4.7% vs. 1.3%)*. There was no difference in permanent study drug discontinuation between Multaq(R) and placebo (30.2% vs. 30.8%).

Dr. Stuart J. Connolly, Director of the division of cardiology at McMaster University, Ontario, Canada and co-principal investigator of the ATHENA trial said "The clinical benefits observed with dronedarone in ATHENA occurred without a significantly higher rate of thyroid or pulmonary disorders compared with placebo reported within the study period."

About the ATHENA Study

The landmark ATHENA study is the only double-blind, antiarrhythmic study in patients with AF that assesses morbidity-mortality. The study was conducted at more than 550 sites in 37 countries and enrolled a total of 4,628 patients.

The patients studied in ATHENA were either 75 years of age or older (with or without cardiovascular risk factors) or below 75 years of age with at least one additional cardiovascular risk factor (hypertension, diabetes, previous ischemic cerebrovascular event, left atrium size greater than 50 mm or left ventricular ejection fraction lower than 40 percent). Patients with recently decompensated heart failure or in New York Heart Association (NYHA) class IV were excluded. Patients were randomized to receive dronedarone 400 mg BID or placebo, with a mean follow-up of 21 months.

The ATHENA study objectives were designed to show a potential benefit of dronedarone
'/>"/>

SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
2. Vaccine Study in New England Journal of Medicine Wrong in Concluding Mercury Exposures are Harmless, States SafeMinds
3. Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
4. The New England Journal of Medicine Publishes First Clinical Results for MedImmunes Chitinase-like Protein YKL-40 in Patients With Asthma
5. New England Journal of Medicine Study Shows ERBITUX(R) Improves Survival in Advanced Colorectal Cancer
6. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
7. New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study
8. The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxters Cell-Based Pandemic, Avian Flu Vaccine
9. The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer
10. New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients
11. Diamyd(R) Study Published in Prestigious New England Journal of Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... 2014 UBM Medica US announces that ... community for primary care clinicians offers a photo collection ... victims of a variety of summer scourges.  ... a host of medical menaces: poison ivy, tick-borne infections, ... the highlights covered on Consultantlive,s topic center that includes ...
(Date:7/21/2014)... 2014 By order of the U.S. Bankruptcy Court, ... of ophthalmic and optical equipment, designer eyeglass frames, and other ... American Optical Services LLC. Online bidding opens July ... succession, live auction style, on July 28 beginning at 10:30 ... be held July 25 th and 26 th ...
(Date:7/21/2014)... Israel , July 21, 2014 Galmed ... clinical-stage biopharmaceutical company focused on the development and commercialization ... liver diseases and cholesterol gallstones, announced today that it ... July 25, 2014 to discuss results for the period ... on current developments with respect to its clinical program ...
Breaking Medicine Technology:ConsultantLive Presents Special Coverage of Summer Scourges 2ConsultantLive Presents Special Coverage of Summer Scourges 3Auction Set For Assets Of National Optical Services Company 2Galmed Pharmaceuticals Second Quarter 2014 Conference Call and Webcast Scheduled for Friday, July 25, 2014 2
... (NYSE Euronext Paris: COX) today announced that the ... with OA of the hip showed a highly,statistically ... of the trial. Naproxcinod 750 mg bid showed ... similar blood pressure profile,to placebo. Naproxcinod is the ...
... Nov. 21 Millions of Americans with moderate to severe ... new treatment option. Today, Johnson & Johnson Pharmaceutical Research ... Drug Administration (FDA) approved tapentadol immediate-release tablets for the relief ... of age or older. , , ...
Cached Medicine Technology:Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results 2Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results 3Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results 4Third Pivotal Phase 3 Study for NicOx' Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results 5FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain 2FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain 3FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain 4FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain 5FDA Approves Tapentadol Immediate-Release Tablets for Relief of Moderate to Severe Acute Pain 6
(Date:7/22/2014)... (PRWEB) July 22, 2014 Kirby Lester, ... medication dispensing device includes streamlined functionality to perform a ... vial-filling robot. , Since a double-count of controlled medications ... hospital pharmacy to quickly perform a second count of ... an archived record of the second count up to ...
(Date:7/22/2014)... One woman who looked at diet pills ... pounds. Unfortunately, the weight loss came at a price – ... her time using the pill, and says her personality changed ... insomnia as a result of the caffeine content of one ... age of 37 because of a diet pill she was ...
(Date:7/22/2014)... 22, 2014 Ronald S. Weaver, ... Inglewood, Calif., today announced a heart transplant patient with ... Counterpulsation (EECP) therapy at Global Cardio Care Centers and ... , The patient, a 55-year-old Hispanic male, also ... Life Program, a nutrition and exercise lifestyle program in ...
(Date:7/22/2014)... 22, 2014 There's great news ... Department of Transportation regulations: all PhysicianOne Urgent Care ... US Department of Transportation (DOT). , To ensure ... DOT enforces strict standards to make sure all ... taxis, trucks, and other commercial vehicles. Recently, the ...
(Date:7/22/2014)... Cumberland Pediatric Dentistry and Orthodontics ... that values anxiety-free dental care for children, while maintaining ... child's dental care. , The orthodontic team is ... infants, adolescents, adults and those with special needs. Whether ... or require unique care, such as cleft palate, Cumberland ...
Breaking Medicine News(10 mins):Health News:Kirby Lester KL1Plus Pharmacy Automation Perfect for Double-Counting & Tracking Prescriptions from Any Pharmacy Robot 2Health News:SlimPlate System Urge Women to Shun Controversial Weight Loss Pills for Healthier Methods Like Portion Control 2Health News:Ronald S. Weaver, MD, Owner of Global Cardio Care Centers, Announces EECP Treatment Success for Cardiomyopathy Patient Who Needed Heart Transplant 2Health News:Ronald S. Weaver, MD, Owner of Global Cardio Care Centers, Announces EECP Treatment Success for Cardiomyopathy Patient Who Needed Heart Transplant 3Health News:PhysicianOne Urgent Care Physicians Become Certified Medical Examiners for DOT Physicals 2Health News:Cumberland Pediatric Dentistry and Orthodontics of Clarksville Welcomes Dr. Peter Wojtkiewicz, Pediatric Orthodontist 2Health News:Cumberland Pediatric Dentistry and Orthodontics of Clarksville Welcomes Dr. Peter Wojtkiewicz, Pediatric Orthodontist 3
... birth control in all the schools of England in a ... ,There are currently 2,409 nurses who work in primary and ... a massive extension, reported the online edition of Daily Mail. ... funded to have at least one full-time qualified nurse working ...
... European Breast Cancer Conference (EBCC-5) have called that patients should ... in the field. Doctors and patient groups said that women ... like Herceptin that could help prolong their survival and well ... and radiation therapy are available to women in the United ...
... of Veterinary Medicine have established a national surveillance ... humans and animals using medical records of pets. ... of Epidemiology. Larry Glickman of the School of ... Hospital, a nationwide chain of veterinary hospitals to ...
... without any warning has become a health hazard today with ... per annum. Internal automatic defibrillators (IAD) have now come to ... these apparatus have brought many back from the brink of ... that approximately 1000 people die each year due to sudden ...
... crisis has its origin in HIV/AIDS, weak health systems and ... die from TB every year, 1.5 million are Africans. ... Research Foundation (AMREF) clinic in the Kenyan slum, revealed that ... infected with HIV. According to Nzioka, about two thirds of ...
... a study by the New England Research Institutes in collaboration ... much or too little// are at a greater risk of ... is based on studies done on over 1709 men, in ... over a period of 15 yrs. ,According to ...
Cached Medicine News:Health News:Pets As Disease Watchdogs 2Health News:Seconds Between Life And Death 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: